SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain 10.5% Passive Stake in VAXCYTE INC
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, confirming a 10.5% beneficial ownership stake in VAXCYTE INC as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson, through various affiliated entities, collectively beneficially own 13,054,144.73 shares of VAXCYTE INC's Common Stock.
- This ownership represents 10.5% of the total outstanding shares of VAXCYTE INC.
- FMR LLC holds sole voting power over 12,871,636.00 shares and sole dispositive power over 13,054,144.73 shares.
- Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same aggregate amount of shares (13,054,144.73) due to her control interest in FMR LLC.
- The filing is an Amendment No. 6 to a previously filed Schedule 13G, indicating an ongoing disclosure of a passive investment.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of VAXCYTE INC.
Sentiment
Score: 5
Explanation: The document is a factual, regulatory filing (Schedule 13G) disclosing beneficial ownership. It contains no forward-looking statements, financial performance data, or qualitative assessments that would indicate a positive or negative sentiment. It is purely informational regarding a passive investment stake.
Positives
- The disclosure of a significant 10.5% stake by a major institutional investor like FMR LLC can be viewed as a vote of confidence in VAXCYTE INC's long-term prospects by a sophisticated market participant.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a passive investment stake by a large asset manager in a publicly traded company. It does not provide specific insights into VAXCYTE INC's operational performance or broader industry trends, but rather confirms the continued interest of a significant institutional shareholder.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence investor confidence and market perception.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC and its direct and indirect subsidiaries. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting date for beneficial ownership). |
| 2025-02-11 | Date the Schedule 13G Amendment No. 6 was signed. |
Keywords
VAXCYTE INC, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investor, passive investment, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.